At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of Pigmented Skin Lesions With MelaFind(R) System
In Brief
A Phase 3 clinical trial evaluating MelaFind(R) for Melanoma. Completed, enrolled 1,383 participants across 2 sites.
Detailed Summary
The purpose of this clinical trial is to demonstrate that MelaFind®, a new instrument that uses machine vision for non-invasive early detection of cutaneous pigmented malignant melanoma, is safe and effective. MelaFind® acquires digital images of the lesion with illumination in different spectral bands, from visible to near infrared, and automatically analyzes these images. Diagnostic accuracy of MelaFind® and that of study dermatologists will be evaluated. The reference standard will be final interpretation of lesions by central dermatohistopathology.
Study Details
Timeline
Interventions
Biopsy ratio comparison